Please login to the form below

Not currently logged in
Email:
Password:

Research and Development

This page shows the latest Research and Development news and features for those working in and with pharma, biotech and healthcare.

Pfizer enters late-stage haemophilia B gene therapy trial

Pfizer enters late-stage haemophilia B gene therapy trial

Katherine High, president and head of research and development, Spark Therapeutics, said: “The initiation of the Phase III programme marks an important milestone toward our goal of one day potentially eliminating ... Brenda Cooperstone, senior vice

Latest news

More from news
Approximately 10 fully matching, plus 682 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 82 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Meanwhile, Silence Therapeutics has also bolstered its leadership team with the addition of Richard Jenkins, who joins the group following 28 years’experience in clinical development and drug discovery. ... He joins Concept from Eurofins, where he was

  • Axovant poaches Allergan’s and Teva’s chief medical and science officers Axovant poaches Allergan’s and Teva’s chief medical and science officers

    Gavin Corcoran and Michael Hayden join the biopharma. Clinical stage biopharmaceutical group Axovant has appointed Gavin Corcoran as its new executive vice president of research and development. ... Prior to his time at Teva as its president of global

  • Kevin Sin joins GSK Kevin Sin joins GSK

    Kevin Sin has joined GlaxoSmithKline as its senior vice president, head of worldwide business development for pharmaceutical research and development. ... years. Dr Hal Barron, chief scientific officer and president of research and development, GSK, said:

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson. ... oncology, and vice president of emerging brands, working closely with the research and development teams.

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Metrion Biosciences, the specialist ion channel contract research and drug discovery group, has appointed Dr Barry Kenny and Dr Andrew Southan to its board of directors, a move that will see ... He has over 25 years’experience in ion channel research

More from appointments
Approximately 0 fully matching, plus 159 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    Novel technologies, coupled with programmes designed to drive cell and gene research and development, are ushering in a new era of therapies. ... The complex nature of research and development in these therapy areas means the next generation of

  • Life at the end of the Brexit tunnel

    A Vaccines Development and Manufacturing Centre to develop vaccines for clinical trials and emergency epidemics. ... R&D to support innovation at the manufacturing centres . Government has increased investment in research and development over the next 4

  • Investigator meetings deconstructed

    Investigator meetings deconstructed. With our expertise in clinical meetings and our understanding of their significance to the drug development process, we have put together some of our expert insights to help ... As  our own research shows,

  • Forever Angels achievements and development plan for 2016

    Forever Angels achievements and development plan for 2016. Research Partnership is proud to support Forever Angels in their mission of caring for and improving the lives of orphans and abandoned infants ... overcome and future plans so they can continue

  • Life at the end of the Brexit tunnel

    A Vaccines Development and Manufacturing Centre to develop vaccines for clinical trials and emergency epidemics. ... R&D to support innovation at the manufacturing centres . Government has increased investment in research and development over the next 4

More from PMHub
Approximately 3 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics